Repository logo
 
Publication

The Who-When-Why Triangle of CAM Use Among Portuguese IBD Patients

2017-04Journal article Open access
Simple item page
dc.contributor.authorPortela, F
dc.contributor.authorDias, C
dc.contributor.authorCaldeira, P
dc.contributor.authorCravo, M
dc.contributor.authorDeus, J
dc.contributor.authorGonçalves, R
dc.contributor.authorLago, P
dc.contributor.authorMorna, H
dc.contributor.authorPeixe, P
dc.contributor.authorRamos, J
dc.contributor.authorSousa, H
dc.contributor.authorTavares, L
dc.contributor.authorVasconcelos, H
dc.contributor.authorMagro, F
dc.contributor.authorMinistro, P
dc.date.accessioned2018-01-23T16:47:45Z
dc.date.available2018-01-23T16:47:45Z
dc.date.issued2017-04
dc.description.abstractBACKGROUND: The use of complementary and alternative medicines is increasing among chronic patients, particularly those afflicted with inflammatory bowel diseases. AIM: This study aimed to address the prevalence of complementary and alternative medicines use among Portuguese inflammatory bowel diseases' patients. METHODS: Patients were invited to fill an anonymous questionnaire concerning the use of complementary and alternative medicines. RESULTS: Thirty-one per cent of the patients reported having used complementary and alternative medicines in the past, whereas 12% were using them by the time the questionnaire was administered. Fifty-nine per cent of the users did not share this information with their physician, whereas 14% and 8% discontinued their medication and periodical examination, respectively. Steroids prescription (OR=2.880) and a higher instruction level (OR=3.669) were predictors of complementary and alternative medicines use in this cohort. CONCLUSIONS: Roughly a third of Portuguese IBD patients had used CAM. Steroid treatment and an academic degree are associated with CAM use. Given the potential side effects and interactions, patient information about the benefits and limitations of conventional and complementary treatments should be reinforced.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationDig Liver Dis. 2017 Apr;49(4):388-396.pt_PT
dc.identifier.doi10.1016/j.dld.2016.12.031pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.17/2856
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherElsevierpt_PT
dc.subjectAdultpt_PT
dc.subjectCohort Studiespt_PT
dc.subjectComplementary Therapiespt_PT
dc.subjectFemalept_PT
dc.subjectHumanspt_PT
dc.subjectInflammatory Bowel Diseasespt_PT
dc.subjectLogistic Modelspt_PT
dc.subjectMalept_PT
dc.subjectMiddle Agedpt_PT
dc.subjectPatient Compliancept_PT
dc.subjectPortugalpt_PT
dc.subjectSteroidspt_PT
dc.subjectSurveys and Questionnairespt_PT
dc.subjectTreatment Outcomept_PT
dc.subjectCHLC GASpt_PT
dc.titleThe Who-When-Why Triangle of CAM Use Among Portuguese IBD Patientspt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage396pt_PT
oaire.citation.issue4pt_PT
oaire.citation.startPage388pt_PT
oaire.citation.titleDigestive and Liver Diseasept_PT
oaire.citation.volume49pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
DLD 2017.pdf
Size:
874.04 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

GAS - Artigos